GEN1056
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEN1056, covering 2025-11-24 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid Tumors [Phase 1]